Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Rinaldo

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|July 25, 1996
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcomaS J Gao, L Kingsley, D R Hoover, et al.
Annals of Internal Medicine|June 1, 1988
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort StudyH Farzadegan, M A Polis, S M Wolinsky, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversionH Farzadegan, D R Henrard, C A Kleeberger, et al.
Journal of Virology|November 13, 1999
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionR Shankarappa, J B Margolick, S J Gange, et al.
Nature Communications|November 20, 2025
A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infectionF Fouladi, Y Chen, S Bera, et al.
Journal of Virology|February 7, 2001
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyC R Rinaldo, X L Huang, Z Fan, et al.
Journal of Clinical Microbiology|July 16, 1999
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasmaL M Kirstein, J W Mellors, C R Rinaldo, et al.
Annals of Internal Medicine|June 15, 1997
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infectionJ W Mellors, A Muñoz, J V Giorgi, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|July 25, 1996
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcomaS J Gao, L Kingsley, D R Hoover, et al.
Annals of Internal Medicine|June 1, 1988
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort StudyH Farzadegan, M A Polis, S M Wolinsky, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversionH Farzadegan, D R Henrard, C A Kleeberger, et al.
Journal of Virology|November 13, 1999
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionR Shankarappa, J B Margolick, S J Gange, et al.
Nature Communications|November 20, 2025
A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infectionF Fouladi, Y Chen, S Bera, et al.
Journal of Virology|February 7, 2001
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyC R Rinaldo, X L Huang, Z Fan, et al.
Journal of Clinical Microbiology|July 16, 1999
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasmaL M Kirstein, J W Mellors, C R Rinaldo, et al.
Annals of Internal Medicine|June 15, 1997
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infectionJ W Mellors, A Muñoz, J V Giorgi, et al.
Pageof 15